BIOL News and Press, Biolase Inc. From 09/13/23

BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants PR Newswire LAKE FOREST, Calif. , Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Compan...

2023-08-10 18:47:04 ET BIOLASE, Inc. (BIOL) Q2 2023 Earnings Conference Call August 10, 2023 04:30 PM ET Company Participants Todd Kehrli - EVC Group John Beaver - President & Chief Executive Officer Jennifer Bright - Chief Financial Officer Conference ...

2023-08-10 16:07:40 ET Biolase press release ( NASDAQ: BIOL ): Q2 Non-GAAP EPS of -$4.24 beats by $1.76 . Revenue of $14.3M (+17.2% Y/Y) misses by $1.06M . 2023 Full Year Financial Guidance BIOLASE is updating its guidance and now expects revenue for the ...

BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR PR Newswire Continues to Experience Positive Momentum and Expects to Achieve Improved Net Income and Positive Adjusted EBITDA for the Second Half of 2023 LAKE FOREST,...

2023-08-09 17:35:01 ET Biolase ( NASDAQ: BIOL ) is scheduled to announce Q2 earnings results on Thursday, August 10th, after market close. The consensus EPS Estimate is -$6.00 and the consensus Revenue Estimate is $15.36M (+25.9% Y/Y). Over the last 1 year, BIOL has ...

BIOLASE TO REPORT SECOND QUARTER 2023 RESULTS ON AUGUST 10, 2023 PR Newswire LAKE FOREST, Calif. , Aug. 2, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2023 financi...

2023-07-28 10:11:25 ET Gainers: Reata Pharmaceuticals ( RETA ) +53% . Bluejay Diagnostics ( BJDX ) +48% . INVO Bioscience ( INVO ) +26% . OKYO Pharma ( OKYO ) +24% . BIOLASE ( BIOL ) +10% . Losers: Tonix Pharmaceutica...

2023-07-28 08:23:12 ET Reata Pharmaceuticals ( RETA ) +51% agrees to buy Reata Pharmaceuticals in deal valued at $7.3B . SIGA Technologies ( SIGA ) +32% jumps 27% on U.S. government orders worth $138M. Coursera ( COUR ) +17% Q2 earnings call release INV...

2023-07-26 17:19:32 ET BIOLASE ( NASDAQ: BIOL ) on Wednesday said it would effect a 1-for-100 reverse stock split. The company's common stock will begin trading on a split-adjusted basis on July 28. "The primary purpose of the 1-for-100 reverse stock split is to raise the ...

BIOLASE ANNOUNCES 1-FOR-100 REVERSE STOCK SPLIT PR Newswire COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON JULY 28, 2023 LAKE FOREST, Calif. , July 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Compan...